Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better?

Fischer, 2007, Human primary immunodeficiency diseases, Immunity, 27, 835, 10.1016/j.immuni.2007.11.012 Fischer, 2005, Severe combined immunodeficiency: a model disease for molecular immunology and therapy, Immunol Rev, 203, 98, 10.1111/j.0105-2896.2005.00223.x Levy, 1997, Clinical spectrum of X-linked hyper-IgM syndrome, J Pediatr, 131, 47, 10.1016/S0022-3476(97)70123-9 Imai, 2004, Clinical course of patients with WASP gene mutations, Blood, 103, 456, 10.1182/blood-2003-05-1480 Jones, 2008, Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry, Clin Exp Immunol, 152, 211, 10.1111/j.1365-2249.2008.03644.x van den Berg, 2009, Chronic granulomatous disease: the European experience, PLoS One, 4, e5234, 10.1371/journal.pone.0005234 Antoine, 2003, European Group for Blood and Marrow Transplantation, European Society for Immunodeficiency. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99, Lancet, 361, 553, 10.1016/S0140-6736(03)12513-5 Slatter, 2006, Umbilical cord stem cell transplantation for primary immunodeficiencies, Expert Opin Biol Ther, 6, 555, 10.1517/14712598.6.6.555 Slatter, 2008, Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency, J Allergy Clin Immunol, 121, 361, 10.1016/j.jaci.2007.10.035 Rao, 2005, Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen, Blood, 105, 879, 10.1182/blood-2004-03-0960 Lion, 2003, Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease, Blood, 102, 1114, 10.1182/blood-2002-07-2152 Notarangelo, 2009, Primary immunodeficiencies: 2009 update, J Allergy Clin Immunol, 124, 1161, 10.1016/j.jaci.2009.10.013 Kane, 2001, Neonatal bone marrow transplantation for severe combined immunodeficiency, Arch Dis Child Fetal Neonatal Ed, 85, F110, 10.1136/fn.85.2.F110 Myers, 2002, Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival, Blood, 99, 872, 10.1182/blood.V99.3.872 Baker, 2009, Development of a routine newborn screening protocol for severe combined immunodeficiency, J Allergy Clin Immunol, 124, 522, 10.1016/j.jaci.2009.04.007 Winkelstein, 2003, The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients, Medicine (Baltimore), 82, 373, 10.1097/01.md.0000100046.06009.b0 Gennery, 2004, Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002, Blood, 103, 1152, 10.1182/blood-2003-06-2014 Fernandes, 2009, Comparison of outcomes of mismatched related stem cell and unrelated cord blood transplants in children with severe T-cell deficiencies, Bone Marrow Transplant, 43, S76 Grunebaum, 2006, Bone marrow transplantation for severe combined immune deficiency, JAMA, 295, 508, 10.1001/jama.295.5.508 Neven, 2009, Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency, Blood, 113, 4114, 10.1182/blood-2008-09-177923 Prockop, 2004, Regulation of thymus size by competition for stromal niches among early T cell progenitors, J Immunol, 173, 1604, 10.4049/jimmunol.173.3.1604 Garrod, 2010, NK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivity, J Immunol, 184, 2329, 10.4049/jimmunol.0902748 Fischer, 2005, Severe combined immunodeficiency: a model disease for molecular immunology and therapy, Immunol Rev, 203, 98, 10.1111/j.0105-2896.2005.00223.x Buckley, 1999, Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency, N Engl J Med, 340, 508, 10.1056/NEJM199902183400703 White, 2000, Intrinsic defects of B cell function in X-linked severe combined immunodeficiency, Eur J Immunol, 30, 732, 10.1002/1521-4141(200003)30:3<732::AID-IMMU732>3.0.CO;2-L Sarzotti-Kelsoe, 2009, Thymic output, T cell diversity and T cell function in long-term human SCID chimeras, Blood, 114, 1445, 10.1182/blood-2009-01-199323 Borghans, 2006, Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency, Blood, 108, 763, 10.1182/blood-2006-01-009241 Cavazzana-Calvo, 2007, Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype, Blood, 109, 4575, 10.1182/blood-2006-07-029090 Mazzolari, 2007, Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency, J Allergy Clin Immunol, 120, 892, 10.1016/j.jaci.2007.08.007 Pai, 2006, Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation, Bone Marrow Transplant, 38, 671, 10.1038/sj.bmt.1705512 Filipovich, 2001, Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program, Blood, 97, 1598, 10.1182/blood.V97.6.1598 Seger, 2002, Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000, Blood, 100, 4344, 10.1182/blood-2002-02-0583 Gomez, 1995, Treatment of Omenn syndrome by bone marrow transplantation, J Pediatr, 127, 76, 10.1016/S0022-3476(95)70260-1 Renella, 2006, Br J Haematol, 134, 510, 10.1111/j.1365-2141.2006.06213.x Ozsahin, 2008, Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation, Blood, 111, 439, 10.1182/blood-2007-03-076679 Laffort, 2004, Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency, Lancet, 363, 2051, 10.1016/S0140-6736(04)16457-X Rogers, 2001, Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency, J Pediatr, 139, 44, 10.1067/mpd.2001.115023 Hönig, 2007, Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications, Blood, 109, 3595, 10.1182/blood-2006-07-034678 Griffith, 2008, Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs, J Allergy Clin Immunol, 122, 1087, 10.1016/j.jaci.2008.09.045 Griffith, 2009, Workshop Participants. Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management, J Allergy Clin Immunol, 124, 1152, 10.1016/j.jaci.2009.10.022